Cargando…

High-Dose Therapy and Autologous Hematopoietic Progenitor Cells Transplantation for Recurrent or Refractory Hodgkin's Lymphoma: Analysis of King Hussein Cancer Center Results and Prognostic Variables

Purpose. to evaluate the outcome of patients with Hodgkin's lymphoma who underwent autologous transplantation at KHCC bone marrow transplant program. Patients and Methods. Over 6 years, 63 patients with relapsed or refractory Hodgkin's lymphoma underwent high dose chemotherapy followed by...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdel-Rahman, Fawzi, Hussein, Ayad, Aljamily, Mohammad, Al-Zaben, Abdulhadi, Hussein, Nilly, Addasi, Ala'a
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scholarly Research Network 2012
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3302118/ https://www.ncbi.nlm.nih.gov/pubmed/22518329 http://dx.doi.org/10.5402/2012/249124

Ejemplares similares

Palestinian Patients with Cancer at King Hussein Cancer Center
por: Mansour, Razan, et al.
Publicado: (2022)

Genetic Profile of Patients with Familial Mediterranean Fever (FMF): Single Center Experience at King Hussein Medical Center (KHMC)
por: Habahbeh, Lana Ayesh, et al.
Publicado: (2015)

Analyzing the queuing theory at the emergency department at King Hussein cancer center
por: Qandeel, Mahmoud Salameh, et al.
Publicado: (2023)

Stage I seminoma: treatment outcome at King Hussein Cancer Center in Jordan
por: Khader, Jamal, et al.
Publicado: (2012)

Assessment of Lactate Dehydrogenase Levels Among Diabetic Patients Treated in the Outpatient Clinics at King Hussein Medical Center, Royal Medical Services, Jordan
por: Dmour, Hussein H., et al.
Publicado: (2020)

Oncology pharmacists’ response to COVID-19 pandemic in Jordan: The King Hussein Cancer Center experience
por: Al-Rabayah, Abeer A, et al.
Publicado: (2021)

Oncology Medical Training and Practice: Managing Jordan’s Brain Drain Through Brain Train—The King Hussein Cancer Center Experience
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2020)

Enhancing value of quality assurance rounds in improving radiotherapy management: a retrospective analysis from King Hussein Cancer Center in Jordan
por: Khader, Jamal K., et al.
Publicado: (2019)

Pulmonary Alveolar Microlithiasis: a Case Report in King Hussein Medical Center (KHMC), Amman, Jordan
por: Haddad, Rakan M., et al.
Publicado: (2020)

The burden and scope of childhood cancer in displaced patients in Jordan: The King Hussein Cancer Center and Foundation Experience
por: Rihani, Rawad, et al.
Publicado: (2023)

Cystic Fibrosis Gene Mutation Frequency Among a Group of Suspected Children in King Hussein Medical Center
por: Al-abadi, Baheieh, et al.
Publicado: (2019)

Effect of an educational intervention on the knowledge, attitudes, and practices of healthcare workers at King Hussein Cancer Center towards predatory publishers
por: Al-Ani, Abdallah, et al.
Publicado: (2023)

Using Six Sigma DMAIC Methodology and Discrete Event Simulation to Reduce Patient Discharge Time in King Hussein Cancer Center
por: Arafeh, Mazen, et al.
Publicado: (2018)

Libyan cancer patients at King Hussein Cancer Center for more than a decade, the current situation, and a future vision
por: Erashdi, Madiha, et al.
Publicado: (2023)

Role of Consolidative Radiation Therapy After Autologous Hematopoietic Cell Transplantation for the Treatment of Relapsed or Refractory Hodgkin Lymphoma
por: Wilke, Christopher, et al.
Publicado: (2017)

One Year Primary Patency of Infrapopliteal Angioplasty Using Drug- Eluting Balloons: Single Center Experience at King Hussein Medical Center
por: Haddad, Sizeph Edward, et al.
Publicado: (2017)

Investigating the impact of COVID-19 on patients with cancer from areas of conflict within the MENA region treated at King Hussein Cancer Center
por: Al-Hussaini, Maysa, et al.
Publicado: (2023)

Loss of a Pioneer: Hussein Abdel-Dayem, MD 1934-2017
por: Abdel-Dayem, Essmaeel, et al.
Publicado: (2017)

Autologous hematopoietic stem cell transplantation in classical Hodgkin's lymphoma
por: Cortez, Afonso José Pereira, et al.
Publicado: (2011)

Transformational leadership, transnational culture and political competence in globalizing health care services: a case study of Jordan's King Hussein Cancer Center
por: Moe, Jeffrey L, et al.
Publicado: (2007)

Central nervous system tumors in patients coming from areas of conflict in the Middle East/North Africa region: an experience from King Hussein Cancer Center
por: Obeidat, Mouness, et al.
Publicado: (2023)

Role of Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Hodgkin Lymphoma
por: Carella, Angelo Michele
Publicado: (2012)

High dose chemotherapy and autologous bone marrow transplantation in refractory Hodgkin's disease.
por: Philip, T., et al.
Publicado: (1986)

Peripheral hematopoietic progenitor cell mobilization for autologous transplantation in hematologic malignancies
por: Marques Jr, José Francisco Comenalli
Publicado: (2011)

Hematopoietic progenitor cell mobilization for autologous transplantation – a literature review
por: Salvino, Marco Aurélio, et al.
Publicado: (2016)

Long-Term Survival Analysis and Prognostic Factors of Arabic Patients with Differentiated Thyroid Carcinoma: A 20-Year Observational Study at the King Hussein Cancer Center (KHCC) Involving 528 Patients
por: Al-Ibraheem, Akram, et al.
Publicado: (2023)

Treatment strategies for Hodgkin lymphoma recurring following autologous hematopoietic stem cell transplantation
por: Currin, Erin-Siobhain R., et al.
Publicado: (2012)

Severe autoimmune pancytopenia after autologous hematopoietic stem cell transplantation for Hodgkin lymphoma
por: Fukui, Yuta, et al.
Publicado: (2022)

De Novo Psoriasis Vulgaris Diagnosed after Nivolumab Treatment for Refractory Hodgkin's Lymphoma, Completely Resolved after Autologous Hematopoietic Stem Cell Transplantation
por: Kaloyannidis, Panayotis, et al.
Publicado: (2018)

Current Role of Autologous and Allogeneic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma
por: Castagna, Luca, et al.
Publicado: (2015)

Brentuximab vedotin after autologous transplantation in pediatric patients with relapsed/refractory Hodgkin lymphoma
por: Forlenza, Christopher J., et al.
Publicado: (2023)

Islam postglobal: reflexión alteracadémica inspirada en el Proyecto Imam Hussein
por: Cervera, Felipe
Publicado: (2014)

Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphoma
por: Herrera, Alex F., et al.
Publicado: (2021)

Real-world efficacy of brentuximab vedotin plus bendamustine as a bridge to autologous hematopoietic stem cell transplantation in primary refractory or relapsed classical Hodgkin lymphoma
por: Pinczés, László Imre, et al.
Publicado: (2020)

PB2436: EFFICACY AND SAFETY PROFILE OF EVEROLIMUS AS A MAINTENANCE THERAPY FOR PRIMARY REFRACTORY/RELAPSING HODGKIN LYMPHOMA FOLLOWING AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Zamani, Shayan, et al.
Publicado: (2023)

Remission of refractory Crohn's disease after autologous hematopoietic stem cell transplantation
por: Ruiz, Milton Artur, et al.
Publicado: (2015)

Serum after Autologous Transplantation Stimulates Proliferation and Expansion of Human Hematopoietic Progenitor Cells
por: Walenda, Thomas, et al.
Publicado: (2011)

Circulating CD34+ hematopoietic stem/progenitor cells paralleled with level of viremia in patients chronically infected with hepatitis B virus
por: Abdellatif, Hussein
Publicado: (2018)

Brentuximab vedotin for the treatment of patients with relapsed or refractory Hodgkin lymphoma after autologous stem cell transplantation
por: Kaloyannidis, Panayotis, et al.
Publicado: (2019)

Outcomes of Refractory and Relapsed Hodgkin Lymphoma With Autologous Stem-Cell Transplantation: A Single Institution Experience
por: Wali, Rabia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_r2rq766172idof8v8329clhnmd